Answers are grounded in this paper and cite their sources.
Gram-negative bacteria are endowed with an asymmetric outer membrane (OM), essential for their survival. This asymmetry arises from the unique distribution of lipopolysaccharide (LPS) in the outer leaflet and phospholipids (PLs) in the inner leaflet, which constitute the two essential components of the OM. Bacteria, such as Escherichia coli, maintain a tight balance between LPS and PL biosynthesis, which share (R)-3-hydroxymyristoyl-ACP as a common metabolic precursor. However, the mechanisms that coordinate flux between these pathways remain incompletely understood. Recent discoveries of LapB/C/D (LPS assembly proteins) have provided major insights into this regulation. LapB and LapC regulate the rate-determining step in LPS biosynthesis, mediated by LpxC. LapB also constitutes a hub for proteins involved in LPS, PL, and fatty acid biosynthesis (FAS), including LapD. LapD could regulate initiation of FAS by interaction with acetyl-CoA carboxylase and control phospholipid metabolism via modulating phosphatidylglycerol abundance, explaining pleiotropic phenotypes associated with its absence. Emerging evidence suggests that Lap proteins influence PlsB regulation. Together, these regulatory events coordinate LPS and PL biosynthesis with FAS, which provides acyl chains for both lipid A and PLs to maintain envelope homeostasis. Here, we discuss how Lap proteins participate in LPS and PL biosynthesis, with emphasis on E. coli.
No takes yet. Share an insight, caveat, or question.
Klein et al. (2026) studied this question.
Synapse has enriched 10 related papers. Consider them for comparative context: